1. New Zealand Stocks

  2. •

    Consumer Defensive

  3. •

    Household & Personal Products
Zoono Group Limited

Zoono Group Limited

ZOONF
Zoono Group LimitedUS flagOther OTC
0.03
USD
- -
- -
12.19MMarket Cap
Zoono Group Limited
ZOONF
(Other OTC)

Recent

price

0.03

P/E

ratio

- -

div

yld

- -

ROIC.AI

2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
FRC
- -
- -
- -
- -
- -
- -
- -
- -
0.02
0.01
0.01
0.17
0.12
0.04
0.01
- -
Revenue per Share
-1.09
1.44
-0.66
-3.41
-1.49
-0.65
-2.21
-0.03
-0.09
- -
-0.01
0.07
0.02
-0.05
- -
-0.04
Basic EPS, GAAP
-0.64
-0.61
-0.67
-0.71
-0.42
-0.28
-0.22
-0.08
-0.01
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.02
- -
- -
- -
Dividend per Share
5.28
7.3
6.63
4.15
2.94
1.81
-0.36
-0.04
0.13
0.03
0.02
0.09
0.09
0.04
0.05
0.03
Book Value per Share
6.7
8.23
6.25
4.46
3.17
2.05
-0.32
-0.04
0.13
0.03
0.02
0.09
0.07
0.04
0.05
0.03
Tangible Book Value per Share
1
1
1
1
2
2
2
8
44
216
216
217
217
219
222
219
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
1
2
2
36
25
8
3
1
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
-298.64
-33.29
-137.87
53.48
21.01
-71.42
-175.56
-387.12
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
-1
1
-1
-4
-2
-1
-5
- -
-4
- -
-2
16
4
-10
- -
-8
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
18.38
21.44
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
-515.22
3.28
-136.12
43.46
17.44
-126.4
-10.5
-866.12
Profit Margin (%)
- -
- -
- -
- -
- -
- -
-1
- -
6
6
4
19
19
14
11
7
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
2
1
1
1
LT Debt
7
8
6
5
5
4
-1
- -
6
6
4
20
20
9
10
6
Total Equity
- -
-9.36
- -
- -
- -
- -
- -
- -
- -
-12.6
- -
110.39
17.84
- -
- -
- -
Return on Invested Capital (%)
- -
22.86
- -
- -
- -
- -
- -
- -
- -
1.44
- -
125.67
21.37
- -
- -
- -
Return on Capital (%)
-18.75
22.86
-9.52
-69.12
-49.57
-30.19
- -
- -
- -
1.28
-49.95
133.67
22.42
-70.52
-3.29
-103.79
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-208.31%
70.09%
-38.49%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
-38.42%
241.64%
2,483.28%
Sales/Revenue/Turnover
- -
355.99%
-68.68%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
8
2023
- -
- -
- -
- -
3
2024
- -
- -
- -
- -
1

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
-0.05
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
-0.04

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
Similar Companies
Evergreen Products Group Limited (1962.HK)
Revlon, Inc. (REV)
KOSÉ Corporation (KSRYY)
Pola Orbis Holdings Inc. (4927.T)
Apollo Healthcare Corp. (AHC.TO)
Cheerwin Group Limited (6601.HK)
Business
Zoono Group Limited develops, manufactures and distributes a suite of scientifically validated, long-lasting antimicrobial solutions worldwide. The company offers an extensive range of products including hand sanitisers, surface disinfectants, deodorants, skin lotions, water treatment solutions and shelf-life extension technologies for food packaging; these water-based, alcohol-free formulations create a protective molecular shield that kills 99.9% of germs through physical cell rupture, providing extended protection against bacteria, viruses and pathogens without fostering resistance. Zoono targets consumer, commercial, healthcare, hospitality, transportation and food supply chain markets, with operations spanning New Zealand, Australia, the United Kingdom, South Africa, Namibia and emerging expansions into China and India. Headquartered in Auckland, New Zealand and listed on the ASX under ticker ZNO (OTC: ZOONF), Zoono was founded in 2006 as a biotechnology innovator focused on non-toxic, environmentally friendly hygiene products. In recent developments, Zoono signed an exclusive five-year agreement in November 2025 with Mpact Operations, southern Africa's largest paper, plastics and recycling company, to integrate its antimicrobial technology into corrugated food packaging for grapes, stone fruit and berries across South Africa and Namibia, committing to minimum purchases of NZ$5.1 million; this follows an earlier 2025 exclusive supply deal with a major European food packaging manufacturer's UK division and builds on partnerships like the one with OSY Group for shelf-life extension applications. The company completed a non-renounceable rights issue in August 2025, raising NZ$859,432 to fund supermarket shelf-life projects, market entries in China and India, debt repayment, IP protection and working capital. These strategic alliances and financings underscore Zoono's shift toward food waste reduction and global packaging integration, enhancing commercial adoption of its technology.